2Campbell RK.Glimepiride:role of a new sulfonylurea in the treatment of type 2 diabetes mellitus[J].Ann Pharmcother,1998,32(10):1044.
3Klepzig H,Kober G,Matter C,et al.Sulfonylureas and ischemic preconditioning:A double-blind,placebo-controlled evaluation of glimpiride and glibenclamide[J].Eur Heart J,1999,20(6):439.
4Charpentier G,Vaur L,Halimi S,et al.Predictor of response to glimepiride in patients with type 2 diabetes mellitus[].Diabetes and Metabolism.2001
5Schade DS,Jovanovic L,Schneide J.A placebo-controlled,randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful[].Journal of Clinical Pharmacology.1998
6Raptis SA,Hatziagelaki E,Dimitriadis G,et al.Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations of the fasting and postprandial state in normal men[].Experimental and Clinical Endocrinology and Diabetes.1999
4McKeage K, Goa KL. Insulin glargine: a review of its therapeutic use as a long - acting agent for the management of the type 1 and 2 diabetes mellitus []]. Drugs, 2001, 61 (11): 1599-1624.
5UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glu- cose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patient with type 2 diabetes [ J ]. Lancet, 1999, 354 (9178): 602.
6Alvarsson M, Sundkvist G, Lager I, et al. Effects of insulin vs. glib- enclamide in recently diagnosed patients with type 2 diabetes : a 4 - year follow-up [J]. Diabetes Obes Metab, 2008, 10 (5) : 421 -429.
7Holman RR, Paul SK, Bethel MA, et al. 10 -year follow -up of in- tensive glucose control in type 2 diabetes [ J ]. 2008, 359 ( 15 ) : 1577 - 1589.
8Mtiller G, Wied S. The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephos -pho- rylation in insulin- resistant rat adipocytes in vitro [ J]. Diabetes, 1993, 42 (12): 1852-1867.
9Haupt A, Kausch C, Dahl D, et al. Effect of glimepiride on insulin - stimulated glycogen synthesis in cultured human skeletal muscle cells: a comparison to glibenclamide [ J]. Diabetes Care, 2002, 25 (12) : 2129 -2132.
10Tsunekawa T, Hayashi T, Suzuki Y, et al. Plasma adiponectin plays an important role in improving insulin resistance with glimepiride in eld- erly type 2 diabetic subjects [ J ]. Diabetes Care, 2003, 26 ( 2 ) : 285 - 289.
